This Website uses cookies to provide you with a personalized browsing experience. By using this Website, you agree to our use of cookies as explained in our Privacy Policy. Please read our Privacy Policy for more information on how we use cookies and how you can manage them.

API Development

Active Pharmaceutical Ingredients - API

Cipla’s mission of providing affordable medicines across many therapeutic areas globally is duly supported by the relentless efforts of a team of more than 300 dedicated and talented scientists.

Cipla houses state-of-the-art research facilities for its API process development at three locations in India, with dedicated teams working on synthetic, organic chemistry, process engineering and analytical development at multiple locations.

  • API pipeline consists of 75+ complex developments in the therapy areas of Oncology, Hep C, ARV, Diabetology, CVS, CNS, Respiratory etc.
  • Cipla uses latest technologies like process analytical technology, continuous flow reactors for process development.
  • The products are developed using principles of quality by design, incorporating design of experiments (DOE) to develop robust and cost effective processes.
  • API R&D has dedicated oncology and polypeptide development labs.
  • The API Integrated Product Development (IPD) team has rolled out a programme for adopting principles of Green Chemistry with a vision for developing processes that are friendly to the environment, like use of enzymatic transformations, reducing waste generation and recycling of suitable inputs.
  • Highly experienced analytical research development team houses instrumentation like NMR, LC-MS-MS, GC-MS, PXRD, single crystal XRD etc.

Our capabilities are limitless-from development of a simple achiral molecule to highly complex multi chiral centres molecule with a distinction of affordability and highest quality.

 

Contact Us